[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB201207476D0 - pharmaceutical for the treatment of leishmaniasis - Google Patents

pharmaceutical for the treatment of leishmaniasis

Info

Publication number
GB201207476D0
GB201207476D0 GBGB1207476.1A GB201207476A GB201207476D0 GB 201207476 D0 GB201207476 D0 GB 201207476D0 GB 201207476 A GB201207476 A GB 201207476A GB 201207476 D0 GB201207476 D0 GB 201207476D0
Authority
GB
United Kingdom
Prior art keywords
leishmaniasis
pharmaceutical
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1207476.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mologen AG
Original Assignee
Mologen AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mologen AG filed Critical Mologen AG
Priority to GBGB1207476.1A priority Critical patent/GB201207476D0/en
Publication of GB201207476D0 publication Critical patent/GB201207476D0/en
Priority to PCT/EP2013/059033 priority patent/WO2013164359A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/008—Leishmania antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB1207476.1A 2012-04-30 2012-04-30 pharmaceutical for the treatment of leishmaniasis Ceased GB201207476D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1207476.1A GB201207476D0 (en) 2012-04-30 2012-04-30 pharmaceutical for the treatment of leishmaniasis
PCT/EP2013/059033 WO2013164359A1 (en) 2012-04-30 2013-04-30 Combination vaccine for the treatment of leishmaniasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1207476.1A GB201207476D0 (en) 2012-04-30 2012-04-30 pharmaceutical for the treatment of leishmaniasis

Publications (1)

Publication Number Publication Date
GB201207476D0 true GB201207476D0 (en) 2012-06-13

Family

ID=46330516

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1207476.1A Ceased GB201207476D0 (en) 2012-04-30 2012-04-30 pharmaceutical for the treatment of leishmaniasis

Country Status (2)

Country Link
GB (1) GB201207476D0 (en)
WO (1) WO2013164359A1 (en)

Also Published As

Publication number Publication date
WO2013164359A1 (en) 2013-11-07

Similar Documents

Publication Publication Date Title
HK1197400A1 (en) Compounds for the treatment of hiv hiv
IL237275A0 (en) Compounds for the treatment of paramoxyvirus viral infectiones
IL235058A0 (en) Pharmaceutical combinations for the treatment of metabolic disorders
HUE045947T2 (en) Formulation for the treatment of ibs
GB201205164D0 (en) Pharmaceutical compounds
PL399419A1 (en) Process for the preparation of 4-methoxydihydrochalcone
PL399418A1 (en) Process for the preparation of 4-methoxydihydrochalcone
IL236450A0 (en) Process for the preparation of 5-fluoro-1h-pyrazoles
HK1216619A1 (en) Pharmaceutical compounds
IL234796B (en) Compounds for the treatment of ischemia-reperfusion-related diseases
PL2855475T3 (en) Alpha-carbolines for the treatment of cancer
PL2814462T3 (en) Oil-based pharmaceutical composition for the treatment of gastrointestinal diseases
GB201202027D0 (en) Pharmaceutical compounds
HK1210421A1 (en) Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders -4--20--3-
IL236870B (en) Hydroxystatin derivatives for the treatment of arthrosis
GB201207476D0 (en) pharmaceutical for the treatment of leishmaniasis
PT2812351T (en) Pharmaceutical composition for the treatment of multiple sclerosis
AP2015008270A0 (en) Preparation for the treatment of tuberculosis
GB201215527D0 (en) Compounds for the treatment of muscular dystrophy
IL236873A0 (en) Therapeutic compounds
GB201219236D0 (en) Pharmaceutical compounds
GB201214121D0 (en) Pharmaceutical compounds
GB201213519D0 (en) Pharmaceutical compounds
GB201203253D0 (en) Pharmaceutical compounds
HUP1100245A2 (en) Pharmaceutical composition for the treatment of wounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)